title: Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
abstract: BACKGROUND
  Current practices for renal replacement therapy in intensive care units (ICUs) remain poorly defined. The DOse REsponse Multicentre International collaborative initiative (DO-RE-MI) will address the issue of how the different modes of renal replacement therapy are currently chosen and performed. Here, we describe the study protocol, which was approved by the Scientific and Steering Committees.
  
  
  METHODS
  DO-RE-MI is an observational, multicentre study conducted in ICUs. The primary end-point will be the delivered dose of dialysis, which will be compared with ICU mortality, 28-day mortality, hospital mortality, ICU length of stay and number of days of mechanical ventilation. The secondary end-point will be the haemodynamic response to renal replacement therapy, expressed as percentage reduction in noradrenaline (norepinephrine) requirement. Based on the the sample analysis calculation, at least 162 patients must be recruited. Anonymized patient data will be entered online in electronic case report forms and uploaded to an internet website. Each participating centre will have 2 months to become acquainted with the electronic case report forms. After this period official recruitment will begin. Patient data belong to the respective centre, which may use the database for its own needs. However, all centres have agreed to participate in a joint effort to achieve the sample size needed for statistical analysis.
  
  
  CONCLUSIONS
  The study will hopefully help to collect useful information on the current practice of renal replacement therapy in ICUs. It will also provide a centre-based collection of data that will be useful for monitoring all aspects of extracorporeal support, such as incidence, frequency, and duration.
authors.affiliation: Anesthesiology Clinic, University of Düsseldorf, Germany. Kindgen-Milles@med.uni-duesseldorf.de
authors.forename: Detlef
authors.initials: D
authors.lastname: Kindgen-Milles
authors.forename: Didier
authors.initials: D
authors.lastname: Journois
authors.forename: Roberto
authors.initials: R
authors.lastname: Fumagalli
authors.forename: Sergio
authors.initials: S
authors.lastname: Vesconi
authors.forename: Javier
authors.initials: J
authors.lastname: Maynar
authors.forename: Anibal
authors.initials: A
authors.lastname: Marinho
authors.forename: Irene
authors.initials: I
authors.lastname: Bolgan
authors.forename: Alessandra
authors.initials: A
authors.lastname: Brendolan
authors.forename: Marco
authors.initials: M
authors.lastname: Formica
authors.forename: Sergio
authors.initials: S
authors.lastname: Livigni
authors.forename: Mariella
authors.initials: M
authors.lastname: Maio
authors.forename: Mariano
authors.initials: M
authors.lastname: Marchesi
authors.forename: Filippo
authors.initials: F
authors.lastname: Mariano
authors.forename: Gianpaola
authors.initials: G
authors.lastname: Monti
authors.forename: Elena
authors.initials: E
authors.lastname: Moretti
authors.forename: Daniela
authors.initials: D
authors.lastname: Silengo
authors.forename: Claudio
authors.initials: C
authors.lastname: Ronco
mesh_terms: D001794:Blood Pressure / Q000187:drug effects; D002985:Clinical Protocols; D003299:Cooperative Behavior; D003422:Critical Care / Q000592:standards* / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D004812:Epidemiologic Methods; D006801:Humans; D007362:Intensive Care Units / Q000706:statistics & numerical data; D009638:Norepinephrine / Q000627:therapeutic use; D017582:Renal Replacement Therapy / Q000592:standards*; D012107:Research Design; D016019:Survival Analysis; D013566:Sympathomimetics / Q000627:therapeutic use
chemical_list: D013566:Sympathomimetics; D009638:Norepinephrine